In this episode of This Month in MedTech 2026, April brings a sharper look at where the market is heading.The discussion covers Medtronic’s $100M investment in Pulnovo, why denervation may be turning into a platform strategy, and how China market access could become a bigger part of global MedTech dealmaking. The episode also unpacks Q1 funding trends, cardiovascular M&A, and key deals across thrombectomy, oncology, metabolic disease, lung cancer, and wearable robotics. The bigger message is clear: capital is still moving, but it is becoming more strategic.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.

Episode Breakdown:

00:00 Q1 2026 MedTech Funding Drops Explained

00:55 Intro + This Month in MedTech

02:13 Q1 2026 Funding Recap

04:14 Why Capital Deployment Slowed Down

06:10 Mega Rounds Decline Explained

06:58 Early Stage MedTech Funding Still Stable

07:46 MarketCraft Ad: Engineering Market Pull

11:01 LSI Alumni and Early Stage Funding Trends

12:01 Cardiovascular M&A Momentum

13:22 Stryker’s Surprise Cardiovascular Strategy

15:48 Endovascular Robotics and Platform Wars

18:36 IVL Market Growth + Strategic Acquisitions

19:59 Medtronic’s $100M Bet on Pulnovo

21:00 Why Medtronic is Suddenly Aggressive

22:11 Boston Scientific vs Medtronic Strategy

24:33 Future of Early Stage MedTech Investing

25:54 AI in MedTech Companies

27:17 Pulnovo Technology Explained

28:38 China Market Access Strategy

30:38 Platform Strategy in MedTech

32:46 Deals and Dollars Speed Round

33:21 Cala Health $50M Growth Round

34:03 Calyxo $40M Series F Explained

35:25 Endovascular Engineering $80M Series C

39:20 Sonera Therapeutics Series A

40:27 Endogenex and Metabolic Device Innovation

43:02 GLP-1 Drugs vs Device-Based Therapies

44:25 Hepa Medical Lung Cancer Technology

45:21 Wearable Robotics and Exoskeleton Market

47:34 Biggest Takeaways from April 2026

48:49 Why Platform Companies Are Winning

49:40 Free Trial for Compass AI

51:07 Final Thoughts + Outro

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.

Subscribe to our Youtube Channel

https://www.youtube.com/@thestateofmedtech

Subscribe to our LinkedIn Newsletter

https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

Follow The State of MedTech on

LinkedIn https://www.linkedin.com/company/thestateofmedtech/

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpod

X https://x.com/stateofmedtech

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech

Follow Omar M. Khateeb on

LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok https://www.tiktok.com/@omar.m.khateeb

X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateeb

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

#MedTech #HealthcareInnovation #MedicalDevices #VentureCapital #DigitalHealth

In this episode, Omar Khateeb speaks with Nick Damiano, CEO and Co-Founder of Andromeda Surgical, about how autonomous surgery could redefine surgical robotics.Nick shares how Andromeda is approaching the market differently by focusing on software, autonomy, and real-world surgical data rather than building another traditional robotics platform. The discussion covers their first beachhead in urology, why HoLEP is a powerful starting point, and how better automation could close the gap between novice and expert surgeons.They also explore founder mode in MedTech, why software scales differently than hardware, and how AI-driven robotics could create a new era of surgery for patients, surgeons, and hospitals.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions

Episode Breakdown:

00:00 Autonomous Surgery Vision and Why It Matters

01:08 Intro + Nick Damiano and Andromeda Surgical

02:19 Founder Background and Journey into MedTech

04:32 Why Build Autonomous Surgical Robotics

06:20 Identifying the Right Beachhead Market (Urology)

08:27 Why Not Compete with Existing Surgical Robots

10:13 Why Most MedTech Startups Fail (Market Problem) 

13:27 Inside “Beacon” Platform: Software-First Approach

15:31 How the System Works in Real Procedures

17:08 Why Software is the Real Advantage (Not Hardware)

18:48 TechMed vs MedTech: Choosing the Right Strategy

20:39 Software Scale vs Hardware Limits Explained

22:20 Why Incumbents Will Struggle to Adapt

23:43 Hiring Philosophy: Mindset Over Experience

25:51 Why MedTech Struggles to Attract Top Talent

28:18 Founder Mode vs Traditional CEO Model

30:27 Why Founder-Led Companies Win

32:16 Hiring for Slope vs Skillset Explained

33:05 Building High-Performance Teams

36:21 Clinical Progress + Commercialization Strategy

38:35 Why Utilization Matters More Than Revenue

40:50 Redefining Surgical Robotics Category

43:12 Why Autonomy Will Transform Healthcare

45:42 How the AI System is Trained (Data + Feedback)

47:32 Future of Surgery: Outcomes, Access, Scale

49:55 Where to Find Andromeda + Closing Thoughts

51:00 Outro

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

#medtech #surgicalrobotics #aiinhealthcare #healthcareinnovation #digitalhealth

In this episode, Omar Khateeb, Founder of Marketcraft, shares a focused breakdown of how MedTech companies build toward strong exits. Based on $17B in acquisition insights, this solo episode reframes exits as outcomes of deliberate strategy, not last-minute negotiations. Omar highlights how founders create leverage through early acquirer relationships, clear category positioning, and sustained market presence. He also explains why competitive tension matters, how timing impacts value, and why clinical clarity plays a central role in decision-making. If you want a sharper understanding of how MedTech exits actually happen, this episode gives you a clear and actionable perspective.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.

Episode Breakdown:

00:00 Why Most MedTech Exits Fail (No One Finds You)

00:59 Intro + $17B in Exit Lessons Explained

02:30 Lesson 1: Acquirer Relationships Take Years

05:30 Why Visibility and Narrative Matter

08:00 Lesson 2: The Power of Not Needing to Sell

10:30 Why 85% of Deals Have Only One Buyer 

12:44 Market Problem vs Product Problem

14:18 Strategic Investors Can Reduce Leverage

16:30 Lesson 3: Hard Endpoints vs Surrogate Metrics

19:30 Why Clinical Data Drives Acquisitions

21:53 Lesson 4: Investigators as Strategic Assets

24:30 Why Skeptics Are More Valuable Than Believers

27:00 Lesson 5: Acquirer Culture Matters More Than Price

30:00 Post-Acquisition Success vs Deal Size

31:30 Lesson 6: Phase 2 Data = Maximum Leverage

34:00 Timing Your Exit for Maximum Value

35:30 Lesson 7: CEO Resilience Drives Exit Outcomes

37:12 Final Thoughts + Founder Mindset

37:49 Outro

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

#medtech #mergersandacquisitions #startupstrategy #venturecapital #healthcareinnovation 

In this episode, Omar Khateeb speaks with Dennis McWilliams, Managing Director at Santé Ventures, about what makes a medtech company investable at the early stage.From building Apollo Endosurgery to leading venture investments, Dennis shares how Santé evaluates market size, clinical risk, valuation, and exit potential. He also explains why founders should engage investors early and how disciplined capital strategy shapes outcomes.The episode highlights companies like Farapulse, Laminar, Endogenex, and Sonire Therapeutics, and the role of strategics like Medtronic, Boston Scientific, and Johnson and Johnson in driving acquisitions and growth.A focused look at how medtech capital really moves.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.

Episode Breakdown:

00:00 Harsh Truth About Startup Failure and Capital Risk

00:12 Corporate Venture vs Traditional VC

01:05 Intro + Dennis McWilliams (Sante Ventures)

02:26 Dennis Background: From Aerospace to MedTech

06:05 Why MedTech is Harder Than SaaS

08:04 Lessons from Fund IV and Market Cycles

11:51 Investment Strategy: Early Stage Focus

13:58 Why Valuation Discipline Matters 

16:31 Why Sante Stays Early Stage

18:01 Early vs Late Stage Investing Tradeoffs

21:21 Notable Wins: Cardiovascular and M&A Success

23:32 What Makes a Winning MedTech Company

23:39 Sante Investment Filter Explained

26:06 Evaluating New Markets and White Space

28:05 How VCs Find Startups

30:00 Advice for Founders Raising Capital

33:12 Minimum Requirements to Pitch a VC

35:41 Founder vs Experienced CEO Debate

39:52 When Founders Get Replaced

42:22 What VCs Look for in Founders

43:48 Corporate Venture Capital Explained

46:32 Risks and Dynamics of Corporate Investors

48:00 Founder Mistakes with Equity

48:56 Why Dilution is Misunderstood

51:51 Biggest Startup Mistakes (Valuations)

53:00 How Long VC Decisions Really Take

56:13 New Investment Spotlight (Oncology)

57:36 Rapid Fire: Learning Venture Capital

01:00:01 How Venture Really Works Behind the Scenes

01:02:00 Outro

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

#medtech #venturecapital #startupfunding #healthcareinnovation #entrepreneurship

In this episode, Omar Khateeb, Founder of Marketcraft, takes a focused look at technology adoption and what it really takes to move from early traction to mainstream scale. This solo conversation highlights why many companies gain initial momentum but struggle to sustain growth.Omar explains the shift from vision-driven early adopters to pragmatic mainstream buyers, and why this transition requires more than a strong product. He breaks down the importance of category clarity, repeatable systems, and structured demand creation in driving real adoption. If you want a sharper understanding of how growth actually happens in MedTech, this episode gives you a clear and actionable perspective.

Episode Breakdown:

00:00 Why Most Startups Fail After Early Traction

00:46 Early Adopters vs Early Majority Explained

01:07 Intro + What is Technology Adoption

02:30 Crossing the Chasm Framework Explained

04:30 Technology Adoption Curve Breakdown

06:30 Early Market vs Mainstream Market

09:00 Psychology Shift: Vision vs Pragmatism

11:30 Why Early Traction Doesn’t Scale

13:58 The Traction Gap Explained 

16:00 Minimum Viable Category (MVC) Concept

18:30 Market-Product Fit vs Product-Market Fit

21:00 Why Messaging Breaks in the Chasm

23:30 Signs You're Stuck in the Chasm

25:30 Repeatability vs Scaling Explained

27:30 Beachhead Strategy (D-Day Analogy)

30:00 Category, Messaging, Narrative Framework

32:30 Why Sales and Marketing Fail Without Systems

34:30 How to Cross the Chasm Successfully

36:23 Final Takeaways + Founder Advice

37:00 Outro

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions

#technologyadoption #startupstrategy #medtech #marketanalysis #productmarketfit

In this episode, Omar Khateeb sits down with Kyle Dempsey, Partner at MVM Partners, to unpack what makes a medtech company investable. Kyle shares how MVM evaluates opportunities, why commercial traction matters, and what separates strong companies from those that get overlooked. They also explore how strategics think about acquisitions, why differentiation and market size matter, and how investors assess risk across the commercialization journey. If you want a clearer understanding of medtech investing, commercialization, and exits, this episode delivers exactly that.

Episode Breakdown:

00:00 Why MedTech Wins: Innovation vs Big Strategics

01:04 Intro + Kyle Dempsey (MVM) Background

02:13 Journey: From Medical School to Investing

06:50 What is MVM and How the Fund Evolved

09:41 Portfolio Highlights + Biggest Wins

10:59 Fund Strategy: High Conviction Investing

12:24 What MVM Avoids: DTC and Weak Models

13:58 Why Most MedTech Startups Fail 

16:22 DTC vs B2B Economics in Healthcare

17:25 Why Esthetics is a Tough Category

19:12 What Makes a Great MedTech Company

23:03 Evaluating Competitive Markets

25:49 Winning in Competitive Categories

27:38 Sales Model + Market Size Reality

29:01 Why Big Markets Attract Acquirers

30:56 MedTech Exit Trends + M&A Outlook

33:44 IPO Market vs Acquisition Strategy

36:58 What LPs Care About (DPI vs IRR)

40:07 Fast Returns vs Long-Term Outcomes

41:41 Why Traction Matters More Than Ever

44:33 Bad MedTech Models That Still Get Funded

46:20 Small Markets vs Scalable Opportunities

48:37 TAM vs SAM vs Real Market Potential

51:35 BCI and Neurotech: Hype vs Reality

55:48 MVM Investment Stage + Check Size

01:00:28 AI in MedTech: Feature vs Platform

01:04:25 AI Business Model Challenges

01:07:30 Final Thoughts + Future of MedTech

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions

#medtech #venturecapital #healthcareinnovation #startupstrategy #medicaldevices

In this episode, Omar Khateeb, Founder of Marketcraft, unpacks the real reason most MedTech startups fail to gain traction. This is not a product problem. It is a market problem.He explains how market engineering helps founders define categories, create demand, and move from early innovation to scalable growth. The conversation covers the traction gap, why product market fit is incomplete, and how unclear positioning leads to failed fundraising and slow adoption. If you want a clearer understanding of traction, commercialization, and growth in MedTech, this episode delivers exactly that.

Episode Breakdown

00:00 Why 95% of Startups Fail (It’s Not the Product)

01:21 Intro + What is Market Engineering

02:00 The Real Problem: Market vs Product Failure

04:30 Why Great Products Still Fail

06:30 The Myth of “Build It and They Will Come”

08:30 Product Market Fit is Incomplete

10:30 Defining Market vs Product Fit

12:00 The Traction Gap Explained

14:30 Why Startups Get Stuck Before Scaling

17:00 Minimum Viable Category (Where It All Starts)

19:30 Why Most MedTech Has “No Market”

22:00 Product vs Market Failure (Critical Difference)

24:00 What Real Traction Actually Means

26:30 Early Signs of Real Demand

28:30 Why Launch Hype ≠ Market Validation

30:00 Why Sales and Marketing Won’t Fix This

31:30 Market Engineering Framework (Core Formula)

33:30 Category, Messaging, Narrative, Go-To-Market

35:00 Common Founder Mistakes

36:30 Final Advice: Control Your Category

37:36 Outro + Subscribe

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.

Subscribe to our Youtube Channel

https://www.youtube.com/@thestateofmedtech

Subscribe to our LinkedIn Newsletter

https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

Follow The State of MedTech on

LinkedIn https://www.linkedin.com/company/thestateofmedtech/

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtech⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/StateofMedTech⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Follow Omar M. Khateeb on

LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@omarkhateebofficial⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/OmarMKhateeb⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions

#medtech #startupstrategy #marketanalysis #healthcareinnovation #venturecapital 

In this episode, Omar Khateeb sits down with Lana Ghanem, VP of Corporate Development & Ventures at Hikma Pharmaceuticals and Managing Director at Hikma Ventures, to unpack how corporate venture is reshaping MedTech.

This is not just about capital. It is about how corporate venture teams think, how they assess opportunities, and why most companies never make it past the first conversation.Lana explains why strong traction alone is not enough, and how founders who understand strategic alignment and investor priorities create a clear advantage. The conversation also touches on Hikma’s focus on AI diagnostics, drug development, and scaling healthcare solutions across global markets, especially in the Middle East and North Africa. If you are raising or planning to, this gives you a clearer view of what investors are actually looking for.

Episode Breakdown:

00:00 Middle East Healthcare Reality + Antibiotic Misuse Problem

00:45 Investor Mindset: Why Your Pitch Must Make Sense

00:52 AI Diagnostics and Early Screening Trends

01:23 Intro: Rise of Corporate Venture in MedTech

02:13 Alana Ghanem Background and Career Path

12:00 Why Startups Fail: Market vs Product

12:30 MarketCraft Ad: Market Engineering for Founders

14:59 Board Seat vs Observer Seat Explained

16:37 What Investors Look for Beyond Metrics

17:45 Founder Mistakes and Importance of Preparation

19:51 US vs Global Expansion Strategy

20:30 Drug Delivery Innovation and 505(b)(2) Strategy

21:30 AI in Drug Development: Where Pharma is Heading

23:49 AI Use Cases Beyond R&D (Legal, Ops, Efficiency)

25:42 AI Diagnostics and Early Disease Detection

26:20 Antimicrobial Resistance Challenge in MENA

27:17 Scaling Challenges in MedTech and AI Platforms

28:49 Advice for Founders: Make It an Easy Yes

30:00 Investor Expectations and Decision Process

31:07 How to Reach Hikma Ventures

31:44 Conferences and Networking Opportunities

32:02 Final Thoughts on Pharma + MedTech Convergence

33:00 Outro and Subscribe

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions

 #medtech #healthcareinnovation #digitalhealth #aiinhealthcare #healthtech

See why medical sales teams are getting more done and closing deals thanks to a proactive AI assistant named Donna. Click here to see how Donna can level up your repshttps://www.askdonna.com/industry/medical-devices?utm_source=state_of_medtech

In this episode, Omar Khateeb speaks with George Murgatroyd of Medtronic about the shift toward a digitized operating room. They explore how AI, connected systems, and platforms like Touch Surgery are improving workflows, training, and performance insights. The conversation also covers robotics, data integration, and why interoperability is key to the future of surgery.

Episode Breakdown:

00:58 Introduction to OR Digitization and AI in MedTech

02:03 George Murgatroyd Background and Career Journey

04:10 Music, Creativity, and Early Career Paths

06:00 From NHS to Medtronic Digital Innovation

08:16 The Future of Healthcare and Technology Shift

10:07 Why MedTech Is Falling Behind in AI Adoption

20:25 Can AI Reduce Healthcare Costs While Improving Quality

22:49 Platform vs Ecosystem Thinking in MedTech

26:29 Building Digital Surgery Products at Medtronic

28:53 How Surgeons Actually Learn and Improve Today

29:08 The Technology Behind Surgical Data and Insights

32:00 SaaS in MedTech and Business Model Evolution

44:23 Live Streaming Surgery and Training the Next Generation

46:52 The Talent and Capital Crisis in MedTech

50:34 Ethics, Patients, and Limits of Surgical Broadcasting

53:45 How MedTech Can Attract Top Talent

56:16 Why Mission Still Matters in MedTech Careers

59:02 Apple, Innovation, and Lessons for MedTech

01:01:15 Build vs Buy vs Partner in Digital Health

01:08:16 AI for Surgical Safety and Real-Time Decision Support

01:09:37 Will AI Guide Surgeons Like GPS

01:10:05 Why High-Volume Procedures Will Lead AI Adoption

01:12:28 Complex vs High-Volume Surgery Debate

01:15:30 Which Surgical Specialties Will Adopt AI First

01:17:24 The Next Generation of Surgeons and Digital Expectations

01:20:06 Final Thoughts and Future of MedTech

01:20:30 Music Recommendation and Closing

01:21:52 Outro and Subscribe

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions

#medtech #healthcareinnovation #medicaldevices #healthtech #startupfunding

In this episode, Omar Khateeb sits down with Raymond W. Cohen of Spiro Medical and Thomas A. West of Nalu Medical to unpack the real difference between innovation and iteration in medtech.Drawing from billions in exits and decades of experience, they explain why most companies fall into the trap of incremental thinking and why that approach is becoming harder to fund. The conversation highlights how venture capital behavior has shifted, why larger rounds are often necessary earlier, and how founders need to rethink how they approach building and scaling their companies.They also explore the importance of narrative, not just having a strong technology, but being able to clearly articulate the full journey from idea to commercialization, including reimbursement, manufacturing, and exit strategy.This episode challenges the way most founders think about growth and offers a clearer path to building something that actually stands out.

Episode Breakdown:

00:00 Innovation vs Iteration in MedTech

00:01 Capital, Big Tech, and the Future of Healthcare

00:03 The Real Challenges in MedTech Today

00:05 Meet the Speakers and Keynote Setup

00:10 Are We Truly Innovating?

00:12 What Happens After Acquisition?

00:42 What Investors Actually Look For

00:43 Raising Big for Disruptive Ideas

00:45 Is There Really a Capital Shortage?

00:47 What Investors Bet On

00:48 Building a Winning Story

00:50 Reimbursement and Market Reality

00:53 Why Founders Fail to Convince Investors

00:55 Should You Go After Bigger Problems?

00:57 Exit Strategy and Scaling Decisions

00:59 IPO vs Acquisition

01:00 Public Market Thinking

01:02 Storytelling Drives Capital

01:03 The Reality of Building in MedTech

01:04 Big Tech vs MedTech

01:06 Pharma and New Capital Sources

01:08 Why Disruption Wins

01:09 Owning the Full Business

01:11 Building the Right Team

01:12 Everything Comes Back to Capital

01:13 No Money No Mission

01:14 The Real Impact of MedTech

01:15 Closing Thoughts

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions

#medtech #healthcareinnovation #medicaldevices #healthtech #startupfunding